FIELD: medicine.
SUBSTANCE: invention refers to medicine. What is presented is a lyophilised preparation containing at least one nicotine - virus-like particle conjugate, and a stabiliser composition containing at least one nonreducing disaccharide and at least one non-ionic surfactant wherein the pre-lyophilisation pH value of the stabiliser composition makes 5.8 to 6.6, preferentially 6.0 to 6.4.
EFFECT: invention provides producing the effective lyophilised vaccinal preparation able to keep stability for a long period of time.
14 cl, 3 dwg, 4 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTERLEUKIN-1 CONJUGATES AND THEIR APPLICATION | 2006 |
|
RU2441067C2 |
| CONJUGATES OF HPV-ANTIGEN AND THEIR APPLICATION AS VACCINES | 2005 |
|
RU2417793C2 |
| CAT ALLERGEN FUSED PROTEIN AND APPLICATION THEREOF | 2006 |
|
RU2414239C2 |
| HAPTEN-CARRIER CONJUGATES AND APPLICATION | 2003 |
|
RU2326693C2 |
| VACCINE COMPOSITIONS CONTAINING BETA 1-6 AMYLOID ANTIGEN ARRAY | 2003 |
|
RU2450827C2 |
| COMPOSITION WHICH CONTAINS VIRUS-LIKE PARTICLE (VLP) AND AMYLOID-BETA PEPTIDE | 2005 |
|
RU2415677C2 |
| PACKAGING OLIGONUCLEOTIDES INTO VIRUS-LIKE PARTICLES | 2019 |
|
RU2816533C2 |
| COMPOSITIONS CONTAINING ANTIBODY-DRUG CONJUGATES DUOCARMICIN | 2016 |
|
RU2687237C1 |
| CONJUGATE OF ANGIOTENSIN PEPTIDE COMPONENT WITH CARRIER, VACCINE COMPOSITION, METHOD OF ANIMAL IMMUNISATION AND METHOD OF TREATMENT OR PREVENTION OF PHYSICAL DISORDER RELATED TO ANGIOTENSIN SYSTEM ACTIVATED BY RENIN | 2002 |
|
RU2350622C2 |
| PARTICLES PACKED IN IMMUNOSTIMULATING NUCLEIC ACID THAT INTENDED FOR HYPERSENSITIVITY TREATMENT | 2006 |
|
RU2451523C2 |
